Juan Jose Cubero
Overview
Explore the profile of Juan Jose Cubero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gervasini G, Garcia-Pino G, Mota-Zamorano S, Luna E, Garcia-Cerrada M, Tormo M, et al.
Pharmacogenomics J
. 2019 Dec;
20(3):388-397.
PMID: 31787754
The effect of polymorphims in leptin and adiponectin genes on long-term outcomes of renal transplantation is unknown. In 349 renal transplant recipients (RTR), we aimed to determine associations between five...
2.
Robles N, Ramos J, Chavez E, Gonzalez Candia B, Bayo M, Cidoncha A, et al.
Diabetes Metab Syndr
. 2018 May;
12(6):933-937.
PMID: 29804918
Backgrounds: Iron deficiency has been studied extensively in patients with chronic kidney disease on hemodialysis therapy. However, few studies looked at iron treatment in the non-dialysis chronic kidney disease population....
3.
Hernandez-Gallego R, Cerezo I, Robles N, Barroso S, Romanciuc A, Cubero J
Transpl Infect Dis
. 2017 Oct;
20(1).
PMID: 29064147
Very late-onset cytomegalovirus (CMV) disease after solid organ transplantation is not associated with classic risk factors; therefore, it does not follow a pattern of predictable appearance. A high index of...
4.
Gervasini G, Luna E, Garcia-Pino G, Azevedo L, Mota-Zamorano S, Cubero J
Curr Med Res Opin
. 2017 Oct;
34(2):247-253.
PMID: 29022765
Objective: Arachidonic acid metabolism by cytochrome P450 (CYP) epoxygenases leads to epoxyeicosatrienoic acids (EETs), which are eicosanoids with vasodilator and anti-inflammatory properties. We aim to determine whether genetic variability in...
5.
Hernandez-Gallego R, Cerezo I, Barroso S, Azevedo L, Lopez M, Robles N, et al.
Nefrologia
. 2017 Jul;
37(4):437-439.
PMID: 28750879
No abstract available.
6.
Robles N, Mena C, Chavez E, Bayo M, Gonzalez Candia B, Cidoncha A, et al.
J Clin Lab Anal
. 2017 Feb;
32(1).
PMID: 28187233
Aims: Cystatin C have shown to be a renal function parameter with higher sensitivity and specificity than serum creatinine. In tubular diseases, cystatin C degradation and an increase in its...
7.
Torres A, Torregrosa V, Marcen R, Campistol J, Arias M, Hernandez D, et al.
Nefrologia
. 2016 May;
36(3):255-67.
PMID: 27133898
Background And Objectives: The relationship between mineral metabolism disorders, bone fractures and vascular calcifications in kidney transplant recipients has not been established. Method: We performed a cross-sectional study in 727...
8.
Gervasini G, Luna E, Garcia-Cerrada M, Garcia-Pino G, Cubero J
Mol Cell Endocrinol
. 2015 Oct;
419:158-64.
PMID: 26483195
Arachidonic acid (AA) is metabolized by cytochrome P450 (CYP) enzymes to epoxyeicosatrienoic acids (EETs) and 20-hidroxyeicosatetraenoic acid (20-HETE), which play an important role both in renal transplant and diabetes mellitus...
9.
Gervasini G, Garcia-Cerrada M, Coto E, Vergara E, Garcia-Pino G, Alvarado R, et al.
PLoS One
. 2015 Aug;
10(7):e0133563.
PMID: 26230946
Background And Purpose: Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites that play a protective role against damaging processes that may occur after re-oxygenation of the graft. We aimed to investigate...
10.
Gervasini G, Garcia-Cerrada M, Vergara E, Garcia-Pino G, Alvarado R, Fernandez-Cavada M, et al.
Eur J Clin Invest
. 2015 Jul;
45(10):1060-8.
PMID: 26214067
Background: Arachidonic acid (AA) is metabolized by cytochrome P450 (CYP) enzymes to vasoactive metabolites (mainly epoxyeicosatrienoic acids) which are known to play a protective role against damaging processes that may...